Talk Title: How to engineer robust Natural Killer cell therapies

David Finlay is Professor in Immunometabolism in the Schools of Biochemistry and Immunology, and Pharmacy and Pharmaceutical Science at Trinity College Dublin. He was awarded a B.A. (Mod) in Biochemistry in 2001. He completed his PhD (2006) and postdoctoral training at the University of Dundee in Scotland and was elected to fellowship of Trinity College Dublin in 2018. He has been a principal investigator in the Trinity Biomedical Sciences Institute since 2011. His research expertise lies at the interface of immunology and cellular metabolism with a focus on Natural Killer cells and Dendritic cells. His team is revealing novel strategies to modulate immune cell function through targeting metabolism and metabolic signalling pathways. Dr Finlay’s research has been supported by awards including a Science Foundation Ireland Career Development Award in 2014, a European Research Council Consolidator Award and proof of concept award in 2017 and 2023, respectively. More recently Dr Finlay is supported by a 2023 Advanced Laureate award from Research Ireland to study the in vivo metabolism of immune cells at single cell resolution using novel click-chemistry metabolic assay.